De-risking the clinical development of cholesteryl ester transfer protein inhibitors: how much is good enough?

Eur Heart J. 2012 Jul;33(13):1548-50. doi: 10.1093/eurheartj/ehr408. Epub 2011 Oct 31.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology*
  • Endothelium, Vascular / drug effects*
  • Hypertension / physiopathology*
  • Male
  • Quinolines / pharmacology*

Substances

  • Anticholesteremic Agents
  • Quinolines
  • torcetrapib